Navigation Links
LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients
Date:12/11/2008

LegalView recently discovered that scientists in Australian were using a skin cancer cream on mesothelioma-infected mice to determine if the cream could provide any benefits to mesothelioma patients. In a majority of the mice, scientists found the cream "curing" the mesothelioma patients.

Denver, CO (PRWEB) December 11, 2008 -- LegalView, the number one legal resource available on the Web, recently reported on its mesothelioma information blog of a scientific discovery that may offer varied levels of relief to mesothelioma cancer patients. Several Australian scientists used a skin cancer cream treatment known as Imiquimod combined with an additional cancer treatment known as antiCD40 to treat mesothelioma tumor patients. Nearly 50 percent of the mice tested in the study showed positive results, although treatment side effects were found to be severe.

Mesothelioma is a rare form of cancer that is caused by the exposure and inhalation of asbestos fibers and dust. Unfortunately, many individuals are at risk for the development of the cancer even those who were not employed in occupations where asbestos was readily available at high exposure levels. Asbestos was used in several products as well as during the construction of homes, apartments, hospitals, schools and office/government buildings until its use was banned in the 1970s and 1980s when mesothelioma cancer and the dangers of asbestos began to surface.

Individuals who suffer from mesothelioma cancer or believe they may have the beginnings of mesothelioma cancer should seek medical attention immediately. Additionally, receiving a free legal consultation from an experienced

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3AUDIO from Medialink and Majestic Drug Company 3A When the Tooth Hurts 60261 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 2Shu Tung Li Founder and CEO of Collagen Matrix Inc Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest 60257 1Shu Tung Li Founder and CEO of Collagen Matrix Inc Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest 60257 2